A possible physiological role for cerebral tetrahydroisoquinolines
Tetrahydroisoquinolines present in the mammalian brain, 1,2,3,4-tetrahydroisoquinoline (TIQ) and salsolinol, suspected to cause neurodegeneration leading to Parkinson's disease, were investigated to find their possible physiological role. To this aim their behavioral and receptor effects induced after a single dose were tested in mice and rats. Both compounds do not affect significantly the basal locomotor activity, very effectively block hyperactivity induced by apomorphine (rats) and amphetamine (mice), only partially block hyperactivity induced by scopolamine, do not affect locomotor stimulation induced by cocaine, and strongly augment the running fit induced by morphine (mice). They do not produce extrapyramidal symptoms and do not potentiate haloperidol-induced catalepsy (rats). TIQ and salsolinol do not displace antagonists of several receptors (including D1 and D2) from their binding sites, but displace the agonists of α2-adrenoreceptors, [3H] clonidine and of dopamine receptors, [3H] apomorphine. The results indicate that salsolinol and TIQ act as specific antagonists of agonistic conformation of dopamine receptors, and owing to that may play a role of endogenous feed-back regulators of the dopaminergic system. Those properties make tetrahydroisoquinolines potential antidopaminergic drugs devoid of extrapyramidal effects, with possible application in substance addiction disorder as anti-craving agents.
KeywordsAmphetamine Apomorphine Cocaine Dopamine receptor Hyperactivity Morphine Salsolinol Tetrahydroisoquinolines
Unable to display preview. Download preview PDF.
- Antkiewicz-Michaluk L, A Szczudlik, A Krygowska-Wajs, I Romañska and J Vetulani (1997) Increase in salsolinol level in the cerebrospinal fluid of parkinsonian patients is related to dementia: advantage of a new high-performance liquid chromatography methodology.Biol. Psychiatry 42, 514–518.PubMedCrossRefGoogle Scholar
- Antkiewicz-Michaluk L, I Romanska, I Papla, J Michaluk, M Bakalarz, J Vetulani, A Krygowska-Wajs and A Szczudlik (2000b) Neurochemical changes induced by acute and chronic administration of 1,2,3,4-tetrahydroisoquinoline and salsolinol in dopaminergic structures of rat brain.Neuroscience 96, 59–64.PubMedCrossRefGoogle Scholar
- Deng Y, W Maruyama, M Kawai, P Dostert, H Yamamura, T Takahashi and M Naoi (1997) Assay for the (R)- and (S)-enantiomers of salsolinols in biological samples and foods with ion-pair high-performance liquid chromatography using beta-cyclodextrin as a chiral mobile phase additive.J. Chromatogr. B Biomed. Sci. Appl. 689, 313–320.PubMedCrossRefGoogle Scholar
- Lorenc-Koci E, M Smialowska, L Antkiewicz-Michaluk, K Golembiowska, M Bajkowska and S Wolfarth (2000) Effect of acute and chronic administration of 1,2,3,4-tetrahydroisoquinoline on muscle tone, metabolism of dopamine in the striatum and tyrosine hydroxylase immunocytochemistry in the substantia nigra, in rats.Neuroscience 95, 1049–1059.PubMedCrossRefGoogle Scholar
- Maruyama W, G Sobue, K Matsubara, Y Hashizume, P Dostert and M Naoi (1997) A dopaminergic neurotoxin, 1(R), 2(N)-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline,N-methyl(R)salsolinol, and its oxidation product, 1,2(N)-dimethyl-6,7-dihydroxy-soquinolinium ion, accumulate in the nigro-striatal system of the human brain.Neurosci. Lett. 223, 61–64.PubMedCrossRefGoogle Scholar
- Naoi M, W Maruyama, T Kasamatsu and P Dostert (1998) Oxidation ofN-methyl(R)salsolinol involvement to neurotoxicity and neuroprotection by endogenous catechol isoquinolines.J. Neural Transm. (Suppl.) 52, 125–138.Google Scholar
- Niwa T, N Takeda, H Yoshizumi, A Tatematsu, M Yoshida, P Dostert, M Naoi and T Nagatsu (1991) Presence of 2-methyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline and 1,2-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline, novel endogenous amines, in parkinsonian and normal human brains.Biochem. Biophys. Res. Commun. 177, 603–609PubMedCrossRefGoogle Scholar
- Yamakawa T, Y Kotake, M Fujitani, H Shintani, Y Makino and S Ohta (1999) Regional distribution of parkinsonism-preventing endogenous tetrahydroisoquinoline derivatives and an endogenous parkinsonism-preventing substance-synthesizing enzyme in monkey brain.Neurosci. Lett. 276, 68–70.PubMedCrossRefGoogle Scholar